首页|血清sHLAG、PGⅠ、PGⅡ与早期胃癌的关系及与窄带成像技术的联合诊断价值

血清sHLAG、PGⅠ、PGⅡ与早期胃癌的关系及与窄带成像技术的联合诊断价值

扫码查看
目的 探讨血清可溶性人白细胞抗原-G(sHLAG)、胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)与早期胃癌的关系及与窄带成像技术(NBI)的联合诊断价值.方法 选取 2019 年 3 月—2023 年 4 月于沧州市人民医院诊治的 182 例胃黏膜病变患者作为研究对象,经组织病理检查确诊为胃癌 80 例,胃良性病变 102 例.在病理确诊前行血清sHLAG、PGⅠ、PGⅡ和NBI检查.结果 胃癌组血清sHLAG、PGⅡ高于胃良性病变组,而PGⅠ低于胃良性病变组(P<0.05).不同TNM、分化程度、肿瘤直径、浸润程度胃癌患者的sHLAG、PGⅠ、PGⅡ比较,差异有统计学意义(P<0.05).Kendall's tau-b相关性分析显示,sHLAG、PGⅡ与TNM、分化程度、肿瘤直径、浸润程度呈正相关(P<0.05);PGⅠ与TNM、分化程度、肿瘤直径、浸润程度呈负相关(P<0.05).4 项联合诊断准确率、敏感度分别高于sHLAG、PGⅠ、PGⅡ、NBI单独诊断(P<0.05).结论 血清sHLAG、PGⅠ、PGⅡ在早期胃癌患者中呈异常表达,且与NBI联合有利于提高早期胃癌的诊断效能.
Relationship between serum sHLAG,PGⅠ,PGⅡ and early gastric cancer and their combined diagnostic value with narrow band imaging
Objective To investigate the relationship of serum soluble human leukocyte antigen-G(sHLAG),pepsinogen Ⅰ(PGⅠ),pepsinogen Ⅱ(PGⅡ)with early gastric cancer and the combined diagnostic value with narrow band imaging(NBI).Methods A total of 182 patients with gastric mucosal lesions who were treated in Cangzhou People's Hospital from March 2019 to April 2023 were selected,where 80 gastric cancer patients and 102 benign gastric lesions patients were pathologically diagnosed.Before pathological examination,the levels of serum sHLAG,PGⅠ,PGⅡ and NBI were examined.Results The gastric cancer group showed higher levels of serum sHLAG and PGⅡ and lower levels of PGⅠthan the gastric benign lesion group(P<0.05).There were significant differences in the levels of sHLAG,PGⅠand PGⅡ among gastric cancer patients with different TNM,differentiation degree,tumor diameter and invasion degree(P<0.05).According to Kendall's tau-b correlation analysis,sHLAG and PGⅡ were positively correlated with TNM,differentiation degree,tumor diameter and invasion degree(P<0.05),while PGⅠwas negatively correlated with TNM,differentiation degree,tumor diameter and invasion degree(P<0.05).The diagnostic rate and sensitivity of the four combined indexes were higher than those of sHLAG,PGⅠ,PGⅡ and NBI alone(P<0.05).Conclusions The expression of serum sHLAG,PGⅠ and PGⅡ is abnormal in patients with early gastric cancer,and their combination with NBI is beneficial to improve the diagnostic efficiency of early gastric cancer.

soluble human leukocyte antigen Gpepsinogen Ipepsinogen Ⅱearly gastric cancernarrow band im-aging

史琦玉

展开 >

沧州市人民医院消化内科,河北 沧州 061000

可溶性人白细胞抗原-G 胃蛋白酶原Ⅰ 胃蛋白酶原Ⅱ 早期胃癌 窄带成像技术

河北省重点研发计划

18277759D

2024

徐州医科大学学报
徐州医学院

徐州医科大学学报

CSTPCD
影响因子:0.395
ISSN:2096-3882
年,卷(期):2024.44(3)
  • 17